Moreover, we reviewed the Oncomine database and found that in the Curtis and The Cancer Genome Atlas datasets, the expression of SPA17 in invasive breast carcinoma was higher than that in normal breast, and the difference was statistically significant (Figure 1D). The gene discussed is SPA17; the disease is invasive breast carcinoma.